Share
News
-
21 April 2010 /Authorisation and supervision
The Danish Medicines Agency resumes the allocation of time slots for the second half of 2011
From 3 May 2010 to 31 May 2010 (both days included) the Danish Medicines Agency resumes the allocation of time slots for the second half of 2011.
-
21 April 2010 /Prices and reimbursement
Decision on future reimbursement status of losartan-containing medicines (C09CA01 and C09DA01) - angiotensin II antagonists
On 16 April 2010, the Danish Medicines Agency decided on the future reimbursement status of some of the losartan-containing medicines in ATC groups C09C and C09D, making these products eligible for general reimbursement as of 19 April 2010.
-
09 April 2010 /Prices and reimbursement
Consultation responses on the Reimbursement Committee’s recommendation concerning the reimbursement status of medicinal products in ATC group A02 (drugs for acid related disorders)
The Reimbursement Committee’s recommendation concerning the future reimbursement status of medicinal products in ATC group A02 (drugs for acid related disorders) was open for consultation until 15 March 2010.
-
09 April 2010 /Product areas
The Danish Medicines Agency warns against the use of silicone breast implants manufactured by Poly Implant Prothèse, France
The Danish Medicines Agency warns against the use of silicone gel filled breast implants marked IMGHC-TX, IMGHC-MX or IMGHC-LS manufactured by the French company Poly Implant Prothèse
